Quantitative Investment Management, LLC Geron Corp Transaction History

Quantitative Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $293,304 - $531,432	-290,400 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$0.98 - $1.85 $234,808 - $443,260	239,600 Added 471.65%	290,400 $290,000
Q3 2018 Nov 14, 2018	SELL	$1.76 - $6.38 $389,312 - $1.41 Million	-221,200 Reduced 81.32%	50,800 $89,000
Q2 2018 Aug 10, 2018	SELL	$3.29 - $4.82 $709,653 - $1.04 Million	-215,700 Reduced 44.23%	272,000 $932,000
Q1 2018 May 15, 2018	BUY	$1.81 - $5.98 $882,737 - $2.92 Million	487,700 New	487,700 $2.07 Million

259

450M

1.91M

897K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.59B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.